Publications
60
Citations
860
Est. group size
—
Recurring co-author estimate
Active years
11
Publishing since 2016
Kathryn Nevel conducts clinical research in neuro-oncology, focusing on brain and nervous-system tumors such as gliomas and neurofibromatosis-associated tumors. The work spans drug therapy trials, patient quality-of-life issues, palliative and supportive care, and improved diagnosis and monitoring of brain tumors. Several studies also address medical education and healthcare delivery in neuro-oncology.
Publication activity peaked around 2018-2019 and has since settled into a steadier pace of roughly four to seven papers per year.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Clinical safety and efficacy of bevacizumab in combination with mitogen-activated protein kinase kinase inhibitor therapy for glioma: a retrospective analysis
Neuro-Oncology Pediatrics · 2026
- 288MO Update from the long-term follow-up (LTFU) phase of ReNeu: A pivotal phase IIb trial of mirdametinib in adults and children with neurofibromatosis type 1 (NF1)-associated symptomatic plexiform neurofibroma (PN)
ESMO rare cancers. · 2026
- OS04.4.A RENEU LONG-TERM FOLLOW-UP (LTFU) UPDATE: A PIVOTAL, PHASE 2B TRIAL OF MIRDAMETINIB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS TYPE 1 (NF1)-ASSOCIATED SYMPTOMATIC PLEXIFORM NEUROFIBROMA (PN)
Neuro-Oncology · 2025
- CTNI-06. UPDATE FROM THE LONG-TERM FOLLOW-UP (LTFU) PHASE OF RENEU: A PIVOTAL PHASE 2B TRIAL OF MIRDAMETINIB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS TYPE 1 (NF1)-ASSOCIATED SYMPTOMATIC PLEXIFORM NEUROFIBROMA (PN)
Neuro-Oncology · 2025
- CTNI-07. UNDERSTANDING COMMONLY REPORTED (≥15%) TREATMENT-RELATED ADVERSE EVENTS IN THE RENEU TRIAL OF MIRDAMETINIB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS TYPE 1 (NF1)-ASSOCIATED PLEXIFORM NEUROFIBROMA (PN)
Neuro-Oncology · 2025
- ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma
Journal of Clinical Oncology · 2024
- The impact of brain tumor location and treatment on sexual function: Implications for clinical practice
Elsevier eBooks · 2024
- Immersive Connectivism Learning in Neuro-oncology: A Curriculum Innovation Initiative (P7-7.008)
Neurology · 2024
- Contributors
Elsevier eBooks · 2024
- NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022
Journal of the National Comprehensive Cancer Network · 2023
- Neuro-Oncology Compendium for the Boards and Clinical Practice
2023
- Palliative Care, Rehabilitation, and Supportive Care in Neuro-Oncology
2023
- Practical guidance for telemedicine use in neuro-oncology
Neuro-Oncology Practice · 2022
- Discordance Between Perceptions and Experience of Lumbar Puncture
Neurology Clinical Practice · 2022
- Circulating Tumor Cells and Cell-free Tumor DNA in Evaluation and Management of Gliomas
Advances in Oncology · 2022
- Neuro-Oncology×15
- Neurology×11
- Journal of Clinical Oncology×6
- Current Oncology Reports×2
- Neuro-Oncology Practice×2
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile